Overview Retatrutide is a synthetic, long-acting triple agonist that targets three distinct hormonal receptors: the glucagon-like pep-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor (GCGR)
Retatrutide is still investigational and has not yet become a standard, FDA-approved obesity medication available like semaglutide or tirzepatide
Intestinal Obstruction An intestinal obstruction is a blockage in the small intestine or part of the large intestine that prevents food from passing through a persons digestive tract
Healthcare providers can develop individualized plans balancing symptom management with therapeutic goals, ensuring optimal outcomes while minimizing adverse effects
Notable innovations include: SGLT2 inhibitors improving both glycemic control and kidney health
Now Offering Liraglutide Weight Loss Injections in Basking Ridge Benefits of Liraglutide Significant weight reduction Average 5-10% body weight loss Reduced appetite and cravings Feel satisfied with smaller portions Improved blood sugar control Better glucose regulation Enhanced satiety Stay full longer between meals Cardiovascular benefits Potential heart health improvements Liraglutide vs
